Connect with us

Technology

Cumulus Neuroscience Presents Data at AD/PD™ 2025 Annual Meeting

Published

2 years ago

on

Validation data presented at the 2025 Alzheimer’s & Parkinson’s Diseases (AD/PD) Conference confirms two novel NeuLogiq® Platform endpoints show greater separation with Alzheimer’s pTau217 pathology than the benchmark Alzheimer’s Disease Assessment Scale-Cognitive subscale (ADAS-Cog) 

BELFAST, Northern Ireland, April 4, 2025 /PRNewswire/ — Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient care through improved data and AI, presented NeuLogiq® Platform validation data for two novel assessments of cognitive impairment in Alzheimer’s dementia (AD), and proof-of-concept data in amyotrophic lateral sclerosis and frontotemporal dementia (ALS-FTD) at the AD/PD™ 2025 in Vienna, Austria.

“We are excited to share data validating NeuLogiq Platform cognitive tasks to measure memory, executive function and psychomotor function in broader neurodegenerative indications. We also demonstrated sensitivity to underlying Alzheimer’s pathology, correlating to plasma ptau217 status,” said Brian Murphy, PhD, Founder and Chief Scientific Officer of Cumulus. “Additionally, our CNS-101 study demonstrated that patients could achieve high levels of adherence performing repeated cognitive and EEG tests at home to capture high quality data, making them suitable for use in clinical trials where precise measurement at the individual level is critical. Separately, data presented from our CNS-102 study provides proof-of-concept that NeuLogiq can capture data relevant in ALS-FTD, including patients with profound motor impairments. Collectively, these data confirm that the NeuLogiq Platform has the potential to enable earlier detection of disease and provide biopharma with longitudinal real-world data that can streamline clinical studies.” 

The first poster, titled “Neuropsychological phenotyping of Alzheimer’s dementia at home, using the Cumulus NeuLogiq Platform with plasma biomarkers,” featured data demonstrating that patients are willing and able to perform repeated cognitive and EEG testing at home, and the NeuLogiq Platform endpoints show greater separation with AD pathology (pTau217) than the benchmark endpoint (ADAS-Cog) throughout the study. Importantly, these endpoints accord with standard benchmarks and demonstrate patterns of patient impairment consistent with the literature. EEG biomarkers, including passive and task-based measures, demonstrate morphology and group differences as expected based on the literature.

The second poster titled, “Neurocognitive evaluation from the home: validation of the Cumulus Platform in FTD and ALS populations,” provided initial evidence that the NeuLogiq Platform can capture speech fluency and emotion recognition decline in patients living with ALS, offering potential utility as a digital biomarker of cognitive decline, in addition to providing proof-of-concept that the platform can capture meaningful neuropsychological data, relevant to the heterogeneity of the ALS-FTD phenotype.

Cumulus continues to advance the NeuLogiq Platform, providing biopharma partners and collaborators with a suite of state-of-the-art tools to help advance the discovery and development of new therapies for neuropsychiatric and neurodegenerative conditions. To learn more, visit www.cumulusneuro.com. 

About Alzheimer’s Disease and pTau217
Alzheimer’s is a progressive disease that affects brain function, memory, and other cognitive abilities. It is the most common cause of dementia, affecting millions of people worldwide. Symptoms usually develop slowly and worsen over time, including memory loss, confusion, mood swings, changes in behavior and personality, and difficulty with language and communication. Currently, there is no known cure for Alzheimer’s. Today, earlier diagnosis can enable patients to make lifestyle changes, including exercising and decreasing alcohol consumption, both of which have been shown to slow disease progression. In the future, having the ability to diagnose patients earlier may expedite enrollment in clinical studies and the identification of new treatments. 

pTau217, a phosphorylated fragment of the tau protein, is a promising blood-based biomarker for detecting Alzheimer’s disease (AD) pathology, showing high accuracy in identifying amyloid and tau pathology, and potentially distinguishing AD from other neurodegenerative disorders.

About Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD) 
ALS and FTD are two neurodegenerative diseases that share some similarities but also have distinct characteristics. ALS, also known as Lou Gehrig’s disease, is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, leading to the loss of motor neuron function and eventually causing muscle weakness and paralysis. FTD involves the progressive degeneration of neurons in the areas of the brain behind the forehead (the frontal lobe) and behind the ears (the temporal lobes), leading to changes in personality, behavior, and language. 

About Cumulus Neuroscience 
Our mission is to generate the data and insights required to accelerate the diagnosis and management of central nervous system (CNS) disorders for millions of patients and caregivers around the world. At Cumulus Neuroscience, we are advancing NeuLogiq®, an AI-based, multi-domain digital biomarker platform designed with 10 of the world’s leading pharma companies. This novel platform provides the critical data and insights needed for faster, more robust and cost-effective decision-making in clinical trials and patient care. NeuLogiq enables study sponsors to capture large amounts of real-world clinical data repeatedly over time, across multiple behavioral and physiological domains, in the clinic and at home. Together with machine learning (ML) analytics, Cumulus simplifies and improves the robustness of CNS clinical trials, providing objective assessment of study inclusion and treatment outcomes.

FOR MORE INFORMATION
Tina Sampath
tina.sampath@cumulusneuro.com 
Tel: 415.694.1175

Logo: https://mma.prnewswire.com/media/2657658/Cumulus_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/cumulus-neuroscience-presents-data-at-adpd-2025-annual-meeting-302420326.html

Related Topics:
Continue Reading

Technology

Broadridge Schedules Webcast and Conference Call to Review First Quarter Fiscal Year 2027 Results on November 3, 2026

Published

2 hours ago

on

October 20, 2026

By

NEW YORK, Oct. 20, 2026 /PRNewswire/ — Broadridge Financial Solutions, Inc. (NYSE:BR) is scheduled to release its financial results for the first quarter of fiscal year 2027 on Tuesday, November 3, 2026. Broadridge will host a webcast and conference call to discuss those results at 8:30 a.m. ET on November 3, 2026. Tim Gokey, Chief Executive Officer, and Ashima Ghei, Chief Financial Officer, will participate on the call.

To listen to the live event and access the slide presentation, visit Broadridge’s Investor Relations website at www.broadridge-ir.com prior to the start of the webcast. To listen to the call, investors may also dial 1-877-328-2502 within the United States and international callers may dial 1-412-317-5419.

A replay of the webcast will be available and can be accessed in the same manner as the live webcast at the Broadridge Investor Relations website. A recording of the call will be available through November 10, 2026 by dialing 1-855-669-9658 within the United States or 1-412-317-0088 for international callers, using passcode 4349092 for either dial-in number.

About Broadridge
Broadridge Financial Solutions (NYSE: BR), is a global technology leader with trusted expertise and transformative technology, helping clients and the financial services industry operate, innovate, and grow. We power investing, governance, and communications for our clients – driving operational resiliency, elevating business performance, and transforming investor experiences.

Broadridge’s technology and operations platforms process and generate over 8 billion communications annually and underpin the daily average trading of over $18 trillion in tokenized and traditional securities globally. A certified Great Place to Work®, Broadridge is part of the S&P 500® Index, employing approximately 16,000 associates in 28 countries.

For more information, please visit www.broadridge.com. 

Investor Relations
broadridgeir@broadridge.com                                                      

Media Relations
mediarelations@broadridge.com 

 

View original content:https://www.prnewswire.com/news-releases/broadridge-schedules-webcast-and-conference-call-to-review-first-quarter-fiscal-year-2027-results-on-november-3-2026-302914681.html

SOURCE Broadridge Financial Solutions, Inc.

Continue Reading

Technology

Network Brainiacs Expands into Maryland Through Acquisition of Computer Enhancement Systems in Frederick

Published

2 hours ago

on

October 20, 2026

By

The expansion brings additional technology resources, cybersecurity expertise, and a renewed commitment to client experience to Maryland businesses.

FREDERICK, Md., Oct. 20, 2026 /PRNewswire/ — Network Brainiacs, a managed IT services and cybersecurity company headquartered in Mount Arlington, New Jersey, is pleased to announce its expansion into Maryland through the acquisition of Computer Enhancement Systems (CES), an established IT services provider based in Frederick, Maryland.

The acquisition, effective September 1, 2026, comes shortly after Network Brainiacs celebrated 15 years in business this August. The expansion marks an important chapter in the company’s growth and its continued commitment to helping businesses operate more efficiently, securely, and confidently through technology.

As part of the transition, Network Brainiacs has maintained CES’ existing Frederick location and retained members of its local team. This approach preserves valuable local knowledge and established relationships while introducing new leadership, additional resources, and opportunities to enhance client experience.

“Our mission has always been to make lives more convenient through the seamless integration of technology,” said Victor Magan, CEO of Network Brainiacs. “Expanding into Maryland allows us to bring that commitment to more businesses while building on the relationships CES has developed over the years. We’re excited to combine local experience with additional resources and a fresh perspective on how we can best serve our clients.”

Through this expansion, Maryland businesses will have access to a broader range of technology services, including managed and co-managed IT support, cybersecurity solutions, cloud services, data protection, AI services, application development, technology consulting, and strategic IT planning.

For existing CES clients, the focus is on providing dependable service, strengthening communication, understanding their evolving needs, and identifying opportunities to make their technology experience even better.

“At Network Brainiacs, we believe technology should make people’s lives easier, not more complicated,” said Juana Magan, Chief Experience Officer of Network Brainiacs. “What excites us most about this expansion is the opportunity to connect with more people, learn about their businesses, and build relationships rooted in trust and genuine care. We value what the CES team has built in Frederick, and we look forward to bringing new ideas, strengthening the client experience, and becoming part of this community.”

With locations in New Jersey and Maryland, Network Brainiacs continues to grow its presence while staying committed to the values that guide its work: positivity, teamwork, integrity, a passion for serving others, continuous learning, and finding solutions.

About Network Brainiacs

Founded in 2011, Network Brainiacs is a managed IT services and cybersecurity company headquartered in Mount Arlington, New Jersey, with an additional location in Frederick, Maryland.

The company serves businesses across multiple industries, including healthcare, dental practices, professional services, and small to midsize organizations.

Network Brainiacs provides managed IT services, cybersecurity, cloud solutions, data protection, and strategic technology consulting, with a focus on proactive support, strong relationships, and exceptional client experiences.

Website: www.networkbrainiacs.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/network-brainiacs-expands-into-maryland-through-acquisition-of-computer-enhancement-systems-in-frederick-302914596.html

SOURCE Computer Enhancement Systems (CES)

Continue Reading

Technology

MoonPay and Dunamu to Collaborate on Global Digital Asset Financial Infrastructure

Published

2 hours ago

on

October 20, 2026

By

The two parties are exploring business opportunities in stablecoin payments and corporate treasury management.

Jointly identifying new use cases and business opportunities in stablecoin-based global payments and fund transfersReviewing the potential of digital asset-based financial infrastructure for global corporate finance and treasury managementLinking MoonPay’s global network with Dunamu’s GIWA blockchain to support global ecosystem expansion

NEW YORK, Oct. 20, 2026 /PRNewswire/ — MoonPay, a global crypto payments and stablecoin infrastructure company, is pursuing a strategic collaboration with Dunamu in the field of global financial infrastructure built on digital assets.

The two companies will jointly identify new business opportunities across areas including stablecoin-based global payments and fund movement, and corporate finance and treasury management. By combining MoonPay’s global financial services and network with Dunamu’s technology and business capabilities, including its GIWA blockchain, they plan to explore the potential applications of digital asset-based financial infrastructure.

First, the companies will look for collaboration opportunities in global payments and fund movement using stablecoins. Drawing on both companies’ technology and infrastructure, they will review a range of cases in which digital assets can be used for cross-border payments and fund transfers, and examine the business potential of new financial service models.

The companies will also pursue collaboration in global corporate finance and treasury management. They will jointly review ways to apply digital asset-based financial infrastructure to corporate finance and treasury operations, and identify related business opportunities and usage models.

Expanding Dunamu’s GIWA blockchain ecosystem is another key area of collaboration. Leveraging their respective global ecosystems and partner networks, the two companies will explore ways to broaden access to GIWA-based services and digital assets and strengthen the GIWA ecosystem’s global connectivity. In particular, by linking MoonPay’s global services and network with Dunamu’s blockchain infrastructure, they aim to increase overseas market access for services and assets within the GIWA ecosystem and jointly identify new business opportunities in global markets.

“For stablecoins to function as global financial infrastructure, it is important to have the technology and network to support not only cross-border payments and fund transfers, but also the real financial operations of businesses,” said Bugeon Lee, Head of APAC at MoonPay. “By combining Dunamu’s blockchain capabilities with MoonPay’s global financial infrastructure, we will explore new possibilities for digital assets and work together so that the GIWA ecosystem can expand into global markets.”

Going forward, MoonPay and Dunamu plan to firm up the technical and commercial potential in their main areas of collaboration, namely stablecoin-based global payments, corporate finance and treasury management, and GIWA ecosystem expansion, and to continue identifying new business opportunities that draw on both companies’ strengths.

About MoonPay

MoonPay is a global financial technology company that provides infrastructure for moving value across traditional and digital financial systems. Founded in 2019, MoonPay serves more than 35 million customers in 180 countries and more than 1500 enterprise clients across crypto and fintech. Its products support payments, trading, commerce, stablecoin infrastructure and other services that connect conventional payment networks with blockchain-based financial rails. MoonPay maintains regulatory licenses and authorizations in multiple jurisdictions, including the United States and European Union. For more information, visit www.moonpay.com.

Media Contacts

MoonPay
press@moonpay.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/moonpay-and-dunamu-to-collaborate-on-global-digital-asset-financial-infrastructure-302914516.html

SOURCE MoonPay

Continue Reading

Trending